End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21,550 KRW | -2.49% | -11.32% | -25.69% |
Business Summary
Number of employees: 124
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Tissue Products
78.1
%
| 40,658 | 77.3 % | 53,764 | 78.1 % | +32.23% |
Service
14.6
%
| 9,244 | 17.6 % | 10,023 | 14.6 % | +8.43% |
Human Tissue Merchandise
7.4
%
| 2,671 | 5.1 % | 5,083 | 7.4 % | +90.32% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
94.3
%
| 48,673 | 92.6 % | 64,934 | 94.3 % | +33.41% |
Overseas
5.7
%
| 3,900 | 7.4 % | 3,936 | 5.7 % | +0.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hwan-Chul Lee
CEO | Chief Executive Officer | 48 | - |
Hyung-Gu Kim
BRD | Director/Board Member | 57 | - |
Jong-Oh Choi
AUD | Comptroller/Controller/Auditor | 52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hwan-Chul Lee
CEO | Chief Executive Officer | 48 | - |
Hyung-Gu Kim
BRD | Director/Board Member | 57 | - |
Hae-Seok Hwang
BRD | Director/Board Member | 68 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,684,891 | 15,493,977 ( 68.30 %) | 0 | 68.30 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CUREXO INC. 3.55% | 1,458,221 | 3.55% | 10,381,819 $ |
Company contact information
L&C BIO Co., Ltd.
Unit605-607, Suntech Building 474, Dunchon-daero
13229, Seongnam
+
http://www.lncbio.co.krSector
Sales per Business
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.69% | 365M | |
-0.74% | 12.46B | |
-20.75% | 7.02B | |
+54.95% | 6.61B | |
-31.88% | 4.13B | |
+9.03% | 3.46B | |
-20.14% | 2.52B | |
-19.75% | 1.92B | |
-29.10% | 1.62B | |
-37.42% | 1.48B |
- Stock Market
- Equities
- A290650 Stock
- Company L&C BIO Co.,LTD